149 related articles for article (PubMed ID: 10208019)
1. [Innocuous NSAID: myth or reality?].
Herrerías Gutiérrez JM
An R Acad Nac Med (Madr); 1998; 115(3):659-78; discussion 678-9. PubMed ID: 10208019
[No Abstract] [Full Text] [Related]
2. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
3. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
Morini S; Zullo A
G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
[No Abstract] [Full Text] [Related]
4. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
Vakil N
Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
[TBL] [Abstract][Full Text] [Related]
5. Hospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study.
Rahme E; Nedjar H; Bizzi A; Morin S
Aliment Pharmacol Ther; 2007 Nov; 26(10):1387-98. PubMed ID: 17892525
[TBL] [Abstract][Full Text] [Related]
6. Upper gastrointestinal complications: the causes, consequences, and clinical outcomes.
Am J Manag Care; 2001 Sep; 7(12 Suppl):S397-401. PubMed ID: 11570031
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
Chen JT; Pucino F; Resman-Targoff BH
J Pain Palliat Care Pharmacother; 2006; 20(4):11-32. PubMed ID: 17182503
[TBL] [Abstract][Full Text] [Related]
8. [Recommendation with serious adverse effects].
Ruminski W; Jensen K; Kringelbach TM; Vang O; Bouchelouche PN; Munck LK
Ugeskr Laeger; 2006 Feb; 168(9):928; author reply 928-9. PubMed ID: 16513066
[No Abstract] [Full Text] [Related]
9. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT
Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523
[TBL] [Abstract][Full Text] [Related]
10. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].
MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036
[No Abstract] [Full Text] [Related]
11. [Aspirin and surgery].
García-Sancho Martín L
An R Acad Nac Med (Madr); 1997; 114(4):771-92. PubMed ID: 9616943
[No Abstract] [Full Text] [Related]
12. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
Thiéfin G
Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912
[No Abstract] [Full Text] [Related]
13. NSAIDs and alcohol: never the twain shall mix?
Pfau PR; Lichenstein GR
Am J Gastroenterol; 1999 Nov; 94(11):3098-101. PubMed ID: 10566697
[No Abstract] [Full Text] [Related]
14. [Antiplatelet drugs and gastrointestinal bleeding: numquam periclum sine periclo vincitur].
Rossini R; Lucà MG; Scuri P; Invernizzi P; Strazzabosco M; Gavazzi A
Ital Heart J Suppl; 2005 Oct; 6(10):621-6. PubMed ID: 16273749
[No Abstract] [Full Text] [Related]
15. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
[TBL] [Abstract][Full Text] [Related]
16. Non-steroidal anti-inflammatory drugs and chemoprevention of cancer.
Vainio H; Morgan G
Ann Chir Gynaecol; 2000; 89(3):173-6. PubMed ID: 11079784
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-Inflammatory drugs and cardiovascular risk.
Howard PA; Delafontaine P
J Am Coll Cardiol; 2004 Feb; 43(4):519-25. PubMed ID: 14975457
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and current NSAID use.
Simon LS
J Rheumatol; 1999 Jul; 26(7):1429-31. PubMed ID: 10405924
[No Abstract] [Full Text] [Related]
19. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Steen KS; Lems WF; Dijkmans BA
Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1649-52. PubMed ID: 10494299
[TBL] [Abstract][Full Text] [Related]
20. Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey.
Chey WD; Eswaren S; Howden CW; Inadomi JM; Fendrick AM; Scheiman JM
Aliment Pharmacol Ther; 2006 Mar; 23(5):655-68. PubMed ID: 16480405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
